Clinical trial
A Study To Determine If Two Different Versions Of Topotecan Have The Same…
NCT00259935 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00259935 |
|---|---|
| Title | A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid Tumors |
| Official title | A Study to Determine the Bioequivalence of an Oral Formulation of Topotecan Containing the Drug Substance Manufactured by New Process Relative to the Current Study Formulation of Topotecan in Patients With Advanced Solid Tumors (4C) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lung Cancer, Small Cell |
| Intervention type | Drug |
| Interventions | topotecan |
| Enrollment | 107 |
| Start date | Oct 4, 2004 |
| Primary completion | Jul 5, 2007 |
| Completion | Jul 5, 2007 |
| First posted | Dec 1, 2005 |
| Last update posted | Nov 14, 2017 |
| Countries | Netherlands, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: